Advances in Targeted Autophagy Modulation Strategies to Treat Cancer and Associated Treatment-Induced Cardiotoxicity

Area of Science:

• Biomedical Sciences
• Cellular Biology
• Cardiovascular Research

Background:

• Autophagy, a fundamental cellular process, is crucial for maintaining homeostasis and is implicated in various human diseases.
• Cardiovascular dysfunction (cardiotoxicity) is a significant clinical challenge for cancer patients and survivors, linked to autophagy dysregulation.
• Modulating autophagy is being explored as a therapeutic approach for both cancer and cardiovascular diseases.

Purpose of the Study:

• To review recent advances in targeted autophagy modulation strategies for treating cardiotoxicity during cancer treatment.
• To explore interdisciplinary approaches for translating autophagy discoveries into clinical applications.
• To discuss the safe and effective use of autophagy modulation as a cardioprotective strategy.

Main Methods:

• Focus on non-small molecule autophagy modulators for enhanced targeted therapy.
• Review of nanomedicine applications in autophagy modulation and monitoring.
• Discussion of in vitro models and experimental designs for clinical translation.

Main Results:

• Highlighting novel strategies for targeted autophagy modulation.
• Identifying potential of nanomedicine in managing autophagy-related cardiotoxicity.
• Emphasizing the need for rigorous experimentation to bridge basic research and clinical practice.

Conclusions:

• Targeted autophagy modulation offers a promising avenue for cardioprotection during cancer therapy.
• Interdisciplinary approaches, including nanomedicine, are key to developing effective strategies.
• Further research and clinical translation are essential to optimize autophagy modulation for cancer patients.